• SELECT SITE CURRENCY
Select a currency for use throughout the site
Your Search for 'Colorectal Cancer Market - Global and China forecast, Market Share, size, growth and industry analysis (2010-2017)' returned 5 results - Page 1 of 1
Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the MarketEURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Jan 2011 , Pages: 122lung cancer, breast cancer, colorectal cancer, non-hodgkin’s lymphoma and prostate cancer, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as ...
China In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureEURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 GlobalData, Dec 2011 , Pages: 21317: Urine Analysis, China, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 Figure 18: Clinical Chemistry, China, Company share (%), 2010 Figure 19: Genetic Testing, Market ...
EURO€ 830.00USD$ 1,080.00GBP£ 698.00AUD$ 1,056.00JPY¥ 106,612.00SEK 7 090,00CHF 1'018.00CAD$ 1,100.00
Renub Research, Jan 2011
, Pages: 117
World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast Vaccine Industry - Market Overview For decades vaccines were a neglected corner of the drugs business, with old ...
EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00
GBI Research, Mar 2011
, Pages: 194
medical device industry in 2010. - Annualized market data, forecast and pipeline analysis for oncology, along with profiles of promising pipeline molecules in lung cancer, breast cancer, colorectal cancer ...
EURO€ 5,381.00USD$ 7,000.00GBP£ 4,527.00AUD$ 6,847.00JPY¥ 691,131.00SEK 45 961,00CHF 6'598.00CAD$ 7,133.00
MP Advisors, Jan 2011
, Pages: 391
products, growth strategies for the future, and their key milestones. The Global Pharmaceutical Model is changing. Major pharmaceutical companies continue to under-perform in a market constrained by patent ...